Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
peptides (59) 59
chemistry (58) 58
metallurgy (58) 58
organic chemistry (58) 58
human necessities (52) 52
hygiene (52) 52
medical or veterinary science (52) 52
preparations for medical, dental, or toilet purposes (52) 52
index medicus (51) 51
hiv-1 - immunology (43) 43
hiv antibodies - immunology (40) 40
immunology (38) 38
antibodies, neutralizing - immunology (35) 35
vaccines (31) 31
hiv infections - immunology (29) 29
hiv (28) 28
neutralization tests (28) 28
virology (28) 28
viruses (26) 26
hiv envelope protein gp120 - immunology (24) 24
animals (22) 22
human immunodeficiency virus--hiv (22) 22
specific therapeutic activity of chemical compounds ormedicinal preparations (22) 22
neutralizing antibodies (21) 21
antibodies (20) 20
article (20) 20
binding sites (20) 20
molecular sequence data (20) 20
monoclonal antibodies (20) 20
immunodeficiency-virus type-1 (18) 18
research (18) 18
acquired immune deficiency syndrome--aids (17) 17
amino acid sequence (17) 17
antibodies, monoclonal - immunology (17) 17
monoclonal-antibodies (17) 17
multidisciplinary sciences (17) 17
human monoclonal-antibodies (16) 16
immunoglobulins (16) 16
infectious diseases (16) 16
microbiology (16) 16
aids vaccines - immunology (15) 15
epitopes - immunology (15) 15
life sciences (15) 15
vaccine (15) 15
aids vaccines (14) 14
envelope glycoprotein (14) 14
epitopes (14) 14
human monoclonal-antibody (14) 14
infection (14) 14
female (13) 13
mutation (13) 13
aids (12) 12
biochemistry, molecular biology (12) 12
biomolecules (12) 12
health aspects (12) 12
hiv antibodies (12) 12
hiv envelope protein gp41 - immunology (12) 12
immunization (12) 12
medical research (12) 12
vaccination (12) 12
[sdv.bbm.bs]life sciences [q-bio]/biochemistry, molecular biology/biomolecules [q-bio.bm] (11) 11
investigating or analysing materials by determining theirchemical or physical properties (11) 11
measuring (11) 11
physics (11) 11
potent (11) 11
potent neutralization (11) 11
protection (11) 11
proteins (11) 11
simian immunodeficiency virus - immunology (11) 11
testing (11) 11
virus diseases (11) 11
antigens (10) 10
env gene products, human immunodeficiency virus - immunology (10) 10
gp120 (10) 10
hek293 cells (10) 10
hiv infections - virology (10) 10
human-immunodeficiency-virus (10) 10
infections (10) 10
macaca mulatta (10) 10
pbl-scid mice (10) 10
physiological aspects (10) 10
acquired immune deficiency syndrome (9) 9
biology (9) 9
cd4 antigens - immunology (9) 9
epitope (9) 9
hiv envelope protein gp120 - chemistry (9) 9
hiv infection (9) 9
hiv-1 - genetics (9) 9
macaques (9) 9
passive transfer (9) 9
passive-immunization (9) 9
research article (9) 9
studies (9) 9
viral antibodies (9) 9
antibodies, neutralizing - chemistry (8) 8
antigenic determinants (8) 8
broad (8) 8
cell line (8) 8
enzyme-linked immunosorbent assay (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (181) 181
French (27) 27
German (16) 16
Spanish (2) 2
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Polish (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses
by Dennis R. Burton and Pascal Poignard and Robyn L. Stanfield and Ian A. Wilson
Science, ISSN 0036-8075, 7/2012, Volume 337, Issue 6091, pp. 183 - 186
Certain human pathogens avoid elimination by our immune system by rapidly mutating the surface protein sites targeted by antibody responses, and consequently... 
Antigens | Pathogens | Receptors | Polysaccharides | HIV | Vaccination | Antibodies | Viruses | Orthomyxoviridae | REVIEW | Epitopes | HIV-1 | MEMORY B-CELLS | EPITOPE | HEPATITIS-C VIRUS | STRUCTURAL BASIS | MULTIDISCIPLINARY SCIENCES | ENVELOPE GLYCOPROTEIN | E2 GLYCOPROTEIN | INFLUENZA-A VIRUSES | HUMAN MONOCLONAL-ANTIBODIES | RATIONAL DESIGN | HIV Infections - prevention & control | HIV-1 - pathogenicity | env Gene Products, Human Immunodeficiency Virus - immunology | Antigenic Variation | Hepacivirus - immunology | Humans | AIDS Vaccines - immunology | Models, Molecular | Drug Discovery | HIV Antibodies - chemistry | Orthomyxoviridae - immunology | HIV Infections - immunology | Hepatitis C - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | HIV Antibodies - immunology | Antibodies, Viral - immunology | Influenza Vaccines | Hepatitis C - prevention & control | Influenza, Human - prevention & control | env Gene Products, Human Immunodeficiency Virus - chemistry | Influenza, Human - immunology | Viral antibodies | Care and treatment | Immunology | Atomic properties | Genetic aspects | Research | Immune systems | Influenza | Neutralizing | Vaccines | Human behavior
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Human Circulating PD-1+CXCR3−CXCR5+ Memory Tfh Cells Are Highly Functional and Correlate with Broadly Neutralizing HIV Antibody Responses
by Locci, Michela and Havenar-Daughton, Colin and Landais, Elise and Wu, Jennifer and Kroenke, Mark A and Arlehamn, Cecilia L and Su, Laura F and Cubas, Rafael and Davis, Mark M and Sette, Alessandro and Haddad, Elias K and Poignard, Pascal and Crotty, Shane and Int AIDS Vaccine Initiative Protoc and International AIDS Vaccine Initiative Protocol C Principal Investigators
Immunity, ISSN 1074-7613, 10/2013, Volume 39, Issue 4, pp. 758 - 769
The vast majority of currently licensed human vaccines work on the basis of long-term protective antibody responses. It is now conceivable that an... 
B-CELLS | T-FOLLICULAR HELPER | COMMITMENT | BCL6 | PROTECTION | DYNAMICS | REGULATORS | IMMUNOLOGY | EXPRESSION | PROGRAM | LYMPHOCYTES | Germinal Center - immunology | Humans | Molecular Sequence Data | Gene Expression Profiling | T-Lymphocytes, Helper-Inducer - virology | HIV Infections - immunology | HIV Infections - pathology | Immunity, Humoral | T-Lymphocytes, Helper-Inducer - immunology | B-Lymphocytes - virology | HIV Antibodies - biosynthesis | T-Lymphocytes, Helper-Inducer - pathology | B-Lymphocytes - pathology | Amino Acid Sequence | Gene Expression | Receptors, CXCR5 - genetics | Signal Transduction | HIV Infections - virology | Germinal Center - pathology | Receptors, CXCR5 - immunology | HIV-1 - immunology | B-Lymphocytes - immunology | Antibodies, Neutralizing - biosynthesis | Germinal Center - virology | Receptors, CXCR3 - genetics | Receptors, CXCR3 - immunology | Immunologic Memory | Programmed Cell Death 1 Receptor - immunology | Programmed Cell Death 1 Receptor - genetics | Antigens | Hypotheses | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Infections | Vaccines | Mutation | Gene expression | Viral infections | Immune system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
by Robert Pejchal and Katie J. Doores and Laura M. Walker and Reza Khayat and Po-Ssu Huang and Sheng-Kai Wang and Robyn L. Stanfield and Jean-Philippe Julien and Alejandra Ramos and Max Crispin and Rafael Depetris and Umesh Katpally and Andre Marozsan and Albert Cupo and Sebastien Maloveste and Yan Liu and Ryan McBride and Yukishige Ito and Rogier W. Sanders and Cassandra Ogohara and James C. Paulson and Ten Feizi and Christopher N. Scanlan and Chi-Huey Wong and John P. Moore and William C. Olson and Andrew B. Ward and Pascal Poignard and William R. Schief and Dennis R. Burton and Ian A. Wilson
Science, ISSN 0036-8075, 11/2011, Volume 334, Issue 6059, pp. 1097 - 1103
The HIV envelope (Env) protein gpl20 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly... 
Polysaccharides | HIV | Neutralizing antibodies | RESEARCH ARTICLES | Antibodies | Viruses | Trimers | Epitopes | Grants | Binding sites | Crystal structure | PANEL | TRIMERS | MULTIDISCIPLINARY SCIENCES | IMMUNOGENS | ENVELOPE GLYCOPROTEIN COMPLEX | GP120 | HUMAN-IMMUNODEFICIENCY-VIRUS | MONOCLONAL-ANTIBODIES | TYPE-1 | Antibody Specificity | Mannose - immunology | Disaccharides - metabolism | Humans | Antibodies, Neutralizing - metabolism | Crystallography, X-Ray | Disaccharides - chemistry | Mannosides - chemistry | HIV Envelope Protein gp120 - metabolism | HIV Envelope Protein gp120 - immunology | Mannose - metabolism | Antibodies, Neutralizing - immunology | HIV-1 - physiology | HIV Antibodies - immunology | Immunoglobulin Fab Fragments - metabolism | Oligosaccharides - chemistry | Polysaccharides - chemistry | HIV Envelope Protein gp120 - chemistry | Mannose - chemistry | HIV Antibodies - metabolism | Protein Structure, Tertiary | Cell Line | Models, Molecular | Antibodies, Neutralizing - genetics | Glycosylation | Polysaccharides - immunology | Oligosaccharides - metabolism | HIV Antibodies - chemistry | Polysaccharides - metabolism | HIV-1 - immunology | Hydrogen Bonding | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Oligosaccharides - immunology | Protein Conformation | Mannosides - metabolism | HIV Antibodies - genetics | Immunoglobulin Fab Fragments - immunology | Mutation | Binding Sites, Antibody | Carbohydrate Conformation | Viral antibodies | Physiological aspects | Development and progression | Glycoproteins | HIV (Viruses) | Health aspects | Proteins | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Broad neutralization coverage of HIV by multiple highly potent antibodies
by Walker, Laura M and Huber, Michael and Doores, Katie J and Falkowska, Emilia and Pejchal, Robert and Julien, Jean-Philippe and Wang, Sheng-Kai and Ramos, Alejandra and Chan-Hui, Po-Ying and Moyle, Matthew and Mitcham, Jennifer L and Hammond, Phillip W and Olsen, Ole A and Phung, Pham and Fling, Steven and Wong, Chi-Huey and Phogat, Sanjay and Wrin, Terri and Simek, Melissa D and Koff, Wayne C and Wilson, Ian A and Burton, Dennis R and Poignard, Pascal and Protocol G Principal Investigators
Nature, ISSN 0028-0836, 09/2011, Volume 477, Issue 7365, pp. 466 - 470
Broadly neutralizing antibodies against highly variable viral pathogens are much sought after to treat or protect against global circulating viruses. Here we... 
TRIAL | CROSS-CLADE NEUTRALIZATION | CHALLENGE | ASSAY | PROTECTION | MULTIDISCIPLINARY SCIENCES | VACCINE | IMMUNODEFICIENCY-VIRUS TYPE-1 | HUMAN MONOCLONAL-ANTIBODY | MACAQUES | TITER | Epitope Mapping | AIDS Vaccines - biosynthesis | Human Immunodeficiency Virus Proteins - immunology | Immune Sera - blood | Humans | AIDS Vaccines - immunology | Molecular Sequence Data | Neutralization Tests | HIV - immunology | Epitopes - immunology | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - immunology | Human Immunodeficiency Virus Proteins - chemistry | HEK293 Cells | Glycoproteins - chemistry | Antibodies, Monoclonal - immunology | Cell Line | Immune Sera - immunology | Glycosylation | HIV - isolation & purification | Glycoproteins - immunology | HIV - classification | HIV Infections - therapy | Epitopes - chemistry | Monoclonal antibodies | AIDS vaccines | Research | HIV antibodies | Medical research | Viruses | Vaccines | Cloning | Binding sites
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
by Barouch, Dan H and Whitney, James B and Moldt, Brian and Klein, Florian and Oliveira, Thiago Y and Liu, Jinyan and Stephenson, Kathryn E and Chang, Hui-Wen and Shekhar, Karthik and Gupta, Sanjana and Nkolola, Joseph P and Seaman, Michael S and Smith, Kaitlin M and Borducchi, Erica N and Cabral, Crystal and Smith, Jeffrey Y and Blackmore, Stephen and Sanisetty, Srisowmya and Perry, James R and Beck, Matthew and Lewis, Mark G and Rinaldi, William and Chakraborty, Arup K and Poignard, Pascal and Nussenzweig, Michel C and Burton, Dennis R
Nature, ISSN 0028-0836, 2013, Volume 503, Issue 7475, pp. 224 - 228
Human immunodeficiency virus type 1 (HIV-1)-specific monoclonal antibodies with extraordinary potency and breadth have recently been described. In humanized... 
RESPONSES | MULTIDISCIPLINARY SCIENCES | IN-VIVO | VACCINE | ANTIRETROVIRAL THERAPY | HIV-ANTIBODIES | BROAD | MACAQUES | RECOMBINANT ADENOVIRUS VECTORS | RATIONAL DESIGN | HUMANIZED MICE | DNA, Viral - blood | HIV-1 - immunology | Animals | HIV Antibodies - immunology | Antibodies, Neutralizing - therapeutic use | Viremia - therapy | Antibodies, Monoclonal - therapeutic use | Simian Acquired Immunodeficiency Syndrome - therapy | T-Lymphocytes - immunology | Macaca mulatta | Simian Immunodeficiency Virus - physiology | Prevention | Rhesus monkey | Medical research | Monoclonal antibodies | Physiological aspects | Host-parasite relationships | Medicine, Experimental | Research | HIV infection | Health aspects | Studies | Plasma | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Human immunodeficiency virus--HIV | Mutation | Deoxyribonucleic acid--DNA
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
by Brian Moldt and Eva G. Rakasz and Niccole Schultz and Po-Ying Chan-Hui and Kristine Swiderek and Kimberly L. Weisgrau and Shari M. Piaskowski and Zachary Bergman and David I. Watkins and Pascal Poignard and Dennis R. Burton
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2012, Volume 109, Issue 46, pp. 18921 - 18925
Most animal studies using passive administration of HIV broadly neutralizing monoclonal antibodies (bnMAbs) have associated protection against high-dose... 
Shivs | HIV | Neutralizing antibodies | Vaccination | Sterilization | Antibodies | Monoclonal antibodies | Viruses | Inhibitory concentration 50 | HIV 1 | Animal model | Antibody prophylaxis | Passive transfer | SIV | SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | VAGINAL TRANSMISSION | MULTIDISCIPLINARY SCIENCES | VACCINE | AIDS | MONOCLONAL-ANTIBODY | BROAD | CHIMERIC VIRUS | MACAQUES | animal model | passive transfer | antibody prophylaxis | HIV Infections - prevention & control | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Neutralizing - pharmacology | Macaca mulatta | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV-1 - immunology | Animals | HIV Antibodies - immunology | Immunization, Passive | Female | HIV Antibodies - pharmacology | Antibodies, Monoclonal - immunology | Physiological aspects | Virulence (Microbiology) | Research | HIV (Viruses) | Health aspects | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
by Johannes F. Scheid and Hugo Mouquet and Beatrix Ueberheide and Ron Diskin and Florian Klein and Thiago Y. K. Oliveira and John Pietzsch and David Fenyo and Alexander Abadir and Klara Velinzon and Arlene Hurley and Sunnie Myung and Farid Boulad and Pascal Poignard and Dennis R. Burton and Florencia Pereyra and David D. Ho and Bruce D. Walker and Michael S. Seaman and Pamela J. Bjorkman and Brian T. Chait and Michel C. Nussenzweig
Science, ISSN 0036-8075, 9/2011, Volume 333, Issue 6049, pp. 1633 - 1637
Passive transfer of broadly neutralizing HIV antibodies can prevent infection, which suggests that vaccines that elicit such antibodies would be protective.... 
Germ cells | HIV | B lymphocytes | Neutralizing antibodies | REPORTS | Antibodies | Bone marrow | Plasma cells | Viruses | Trimers | Inhibitory concentration 50 | INDIVIDUALS | MEMORY B-CELLS | NEUTRALIZING ANTIBODIES | EPITOPE | TYPE-1 GP120 | MULTIDISCIPLINARY SCIENCES | GP41 | ENVELOPE GLYCOPROTEIN | RECEPTOR | HUMAN-IMMUNODEFICIENCY-VIRUS | HUMAN MONOCLONAL-ANTIBODIES | Consensus Sequence | Antibody Specificity | Humans | Antibodies, Neutralizing - metabolism | Immunoglobulin Heavy Chains - chemistry | Molecular Sequence Data | Crystallography, X-Ray | HIV Envelope Protein gp120 - metabolism | Genes, Immunoglobulin Heavy Chain | HIV Envelope Protein gp120 - immunology | Immunoglobulin Light Chains - chemistry | HIV Infections - immunology | Antibodies, Neutralizing - immunology | Molecular Mimicry | HIV Antibodies - immunology | Cloning, Molecular | HIV Envelope Protein gp120 - chemistry | Binding Sites | HIV Antibodies - metabolism | Amino Acid Sequence | CD4 Antigens - immunology | Antibody Affinity | HIV Antibodies - chemistry | Antibodies, Neutralizing - chemistry | Immunoglobulin Fab Fragments - chemistry | Protein Conformation | Mutation | Binding Sites, Antibody | CD4 Antigens - metabolism | HIV antibodies | Physiological aspects | Genetic aspects | Research | Nucleotide sequencing | Health aspects | Protein binding | Proteins | Immunoglobulins | Vaccines | Human immunodeficiency virus--HIV | Binding sites | Polyclonal antibodies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques
by Tehrani, David M and Parren, Paul W H I and Hessell, Ann J and Poignard, Pascal and Burton, Dennis R and Hunter, Meredith and Bleeker, Wim K and Hangartner, Lars and Marx, Preston A
Nature Medicine, ISSN 1078-8956, 08/2009, Volume 15, Issue 8, pp. 951 - 954
Neutralizing antibodies are thought to be crucial for HIV vaccine protection, but studies in animal models suggest that high antibody concentrations are... 
NONHUMAN-PRIMATES | MEDICINE, RESEARCH & EXPERIMENTAL | NEUTRALIZING ANTIBODIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | PASSIVE TRANSFER | HUMAN MONOCLONAL-ANTIBODY | AIDS | HUMAN-IMMUNODEFICIENCY-VIRUS | HIV PRECLINICAL INTERVENTIONS | SEXUAL TRANSMISSION | TYPE-1 INFECTION | CELL BIOLOGY | HIV-1/SIV CHIMERIC VIRUS | SAIDS Vaccines - administration & dosage | Immunization - methods | Neutralization Tests | Treatment Outcome | HIV - immunology | Antibody Formation - physiology | Simian Acquired Immunodeficiency Syndrome - blood | Simian Acquired Immunodeficiency Syndrome - prevention & control | Chimera - immunology | Animals | Simian Acquired Immunodeficiency Syndrome - immunology | Titrimetry | Immunization Schedule | Chimera - virology | Macaca | Antibodies, Viral - administration & dosage | Simian Immunodeficiency Virus - immunology | Prevention | AIDS vaccines | Usage | Animal models in research | Macaques | Models | Research | Health aspects | HIV infection | Animal diseases | Viruses | Animal vaccines | Monkeys & apes | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
by Laura M. Walker and Sanjay K. Phogat and Po-Ying Chan-Hui and Denise Wagner and Pham Phung and Julie L. Goss and Terri Wrin and Melissa D. Simek and Steven Fling and Jennifer L. Mitcham and Jennifer K. Lehrman and Frances H. Priddy and Ole A. Olsen and Steven M. Frey and Phillip W. Hammond and Stephen Kaminsky and Timothy Zamb and Matthew Moyle and Wayne C. Koff and Pascal Poignard and Dennis R. Burton and Protocol G Principal Investigators
Science, ISSN 0036-8075, 10/2009, Volume 326, Issue 5950, pp. 285 - 289
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals, define critical epitopes for HIV vaccine design. Using a... 
Antigens | B lymphocytes | Neutralizing antibodies | Vaccination | Antibodies | Viruses | Cultured cells | Reports | Trimers | Epitopes | HIV 1 | SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS | DESIGN | EPITOPE | PROTECTION | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | ENVELOPE | MACAQUES | GP120 | MONOCLONAL-ANTIBODIES | V2 DOMAIN | HIV Envelope Protein gp41 - immunology | Lymphocyte Activation | Humans | Protein Multimerization | AIDS Vaccines - immunology | Africa South of the Sahara | Neutralization Tests | Epitopes - immunology | HIV Envelope Protein gp120 - immunology | HIV Infections - immunology | HIV-1 - immunology | HIV Antibodies - immunology | Recombinant Proteins - immunology | Peptide Fragments - immunology | HIV Antibodies - biosynthesis | B-Lymphocyte Subsets - immunology | Immunologic Memory | HIV Envelope Protein gp120 - chemistry | Antibodies, Monoclonal - immunology | Proteins | Immunology | Vaccines | Cellular biology | Human immunodeficiency virus--HIV | Cell culture
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights